These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19781269)
41. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance]. Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088 [TBL] [Abstract][Full Text] [Related]
42. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543 [TBL] [Abstract][Full Text] [Related]
43. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150 [TBL] [Abstract][Full Text] [Related]
44. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511 [TBL] [Abstract][Full Text] [Related]
45. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer]. Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120 [TBL] [Abstract][Full Text] [Related]
46. [Expression of Aurora-B in non-small cell lung cancer and its clinical significance]. Wang WR; Yang SS; Lin JX; Zeng ZY; Liu DM; Liu HT Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1853-6. PubMed ID: 19778810 [TBL] [Abstract][Full Text] [Related]
47. [Expression of HDGF and its implication in stage I non-small cell lung cancer]. Zhou SJ; Xu SF; Zhang HQ; Liu ZD Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933 [TBL] [Abstract][Full Text] [Related]
48. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Zhang Z; Ma J; Li N; Sun N; Wang C Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222 [TBL] [Abstract][Full Text] [Related]
49. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440 [TBL] [Abstract][Full Text] [Related]
50. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer]. Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845 [TBL] [Abstract][Full Text] [Related]
51. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]. Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817 [TBL] [Abstract][Full Text] [Related]
52. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507 [TBL] [Abstract][Full Text] [Related]
53. Proteomic analysis of secreted proteins of non-small cell lung cancer. Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902 [TBL] [Abstract][Full Text] [Related]
54. [Gene diagnosis and prognosis of mediastinal lymph node occult micrometastasis in non-small cell lung carcinoma]. Wang Z; Yin H; Zhang L; Lan X; Li H Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):247-9. PubMed ID: 12515617 [TBL] [Abstract][Full Text] [Related]
55. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma]. Guo QS; Jia H; Han MY; Yu JM; Zhong WX Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785 [TBL] [Abstract][Full Text] [Related]
56. Osteopontin as a marker of weight loss in lung cancer. Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168 [TBL] [Abstract][Full Text] [Related]
57. OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells Hao C; Cui Y; Hu MU; Zhi X; Zhang L; Li W; Wu W; Cheng S; Jiang WG Anticancer Res; 2017 May; 37(5):2245-2254. PubMed ID: 28476789 [TBL] [Abstract][Full Text] [Related]
58. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines. Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589 [TBL] [Abstract][Full Text] [Related]
59. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance]. Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667 [TBL] [Abstract][Full Text] [Related]
60. Osteopontin is a prognostic biomarker in non-small cell lung cancer. Kongsgaard A; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]